{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:54:00Z","timestamp":1790394840460,"version":"4.1.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T00:00:00Z","timestamp":1531353600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["project ? 17-14-01097"],"award-info":[{"award-number":["project ? 17-14-01097"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00766","type":"journal-article","created":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T04:28:22Z","timestamp":1531369702000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Autoregulation of Acetylcholine Release and Micro-Pharmacodynamic Mechanisms at Neuromuscular Junction: Selective Acetylcholinesterase Inhibitors for Therapy of Myasthenic Syndromes"],"prefix":"10.3389","volume":"9","author":[{"given":"Konstantin A.","family":"Petrov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny E.","family":"Nikolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1476-5381.1981.tb10446.x","article-title":"The effects of atropine and oxotremorine on acetylcholine release in rat phrenic nerve-diaphragm preparations.","volume":"73","author":"Abbs","year":"1981","journal-title":"Br. J. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/0896-6273(94)90331-X","article-title":"Acetylcholinesterase density and turnover number at frog neuromuscular junctions, with modeling of their role in synaptic function.","volume":"12","author":"Anglister","year":"1994","journal-title":"Neuron"},{"key":"B3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1113\/JP270213","article-title":"New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction.","volume":"595","author":"Arbour","year":"2017","journal-title":"J. Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/BF00168599","article-title":"The effects of muscarine and atropine reveal that inhibitory autoreceptors are present on frog motor nerve terminals but are not activated during transmission.","volume":"343","author":"Arenson","year":"1991","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neures.2017.11.014","article-title":"Presynaptic active zones of mammalian neuromuscular junctions: nanoarchitecture and selective impairments in aging.","volume":"127","author":"Badawi","year":"2018","journal-title":"Neurosci. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.mcn.2010.09.010","article-title":"Distinct localization of collagen Q and PRiMA forms of acetylcholinesterase at the neuromuscular junction.","volume":"46","author":"Bernard","year":"2011","journal-title":"Mol. Cell. Neurosci."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00123","article-title":"Fine localization of acetylcholinesterase in the synaptic cleft of the vertebrate neuromuscular junction.","volume":"11","author":"Blotnick-Rubin","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/WCO.0b013e328357a829","article-title":"Autoimmune mechanisms in myasthenia gravis.","volume":"25","author":"Cavalcante","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"B9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-3565(25)26634-4","article-title":"The effect of acetylcholine on neuromuscular transmission in the frog.","volume":"142","author":"Ciani","year":"1963","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.4155\/fmc.11.112","article-title":"Conformational adaptation in drug-target interactions and residence time.","volume":"3","author":"Copeland","year":"2011","journal-title":"Future Med. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nrd2082","article-title":"Drug-target residence time and its implications for lead optimization.","volume":"5","author":"Copeland","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.1152\/jn.1996.76.6.3910","article-title":"Presynaptic A1 inhibitory\/A2A facilitatory adenosine receptor activation balance depends on motor nerve stimulation paradigm at the rat hemidiaphragm.","volume":"76","author":"Correia-de-S\u00e1","year":"1996","journal-title":"J. Neurophysiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1083\/jcb.34.1.157","article-title":"Electron microscopic localization of acetylcholinesterase and nonspecific cholinesterase at the neuromuscular junction by the gold-thiocholine and gold-thiolacetic acid methods.","volume":"34","author":"Davis","year":"1967","journal-title":"J. Cell Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1111\/j.1460-9568.2007.05770.x","article-title":"The time course of transmitter release in mouse motor nerve terminals is differentially affected by activation of muscarinic M1 or M2 receptors.","volume":"26","author":"Dudel","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1113\/jphysiol.1979.sp012917","article-title":"Inhibitory effects of cholinergic agents on the release of transmitter at the frog neuromuscular junction.","volume":"294","author":"Duncan","year":"1979","journal-title":"J. Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cbi.2010.01.042","article-title":"Acetylcholinesterase: from 3D structure to function.","volume":"187","author":"Dvir","year":"2010","journal-title":"Chem. Biol Interact."},{"key":"B17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.nurt.2007.01.001","article-title":"The therapy of congenital myasthenic syndromes.","volume":"4","author":"Engel","year":"2007","journal-title":"Neurotherapeutics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.14670\/HH-20.733","article-title":"Expression of muscarinic acetylcholine receptors (M1-, M2-, M3- and M4-type) in the neuromuscular junction of the newborn and adult rat.","volume":"20","author":"Garcia","year":"2005","journal-title":"Histol. Histopathol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.30839","article-title":"Activity-induced Ca2+ signaling in perisynaptic Schwann cells of the early postnatal mouse is mediated by P2Y1 receptors and regulates muscle fatigue.","volume":"7","author":"Heredia","year":"2018","journal-title":"eLife"},{"key":"B21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/nyas.13522","article-title":"Myasthenia gravis: the role of complement at the neuromuscular junction.","volume":"1412","author":"Howard","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.celrep.2017.11.008","article-title":"Cellular and molecular anatomy of the human neuromuscular junction.","volume":"21","author":"Jones","year":"2017","journal-title":"Cell Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1098\/rspb.1975.0149","article-title":"The nature of the prolonged endplate depolarization in anti-esterase treated muscle.","volume":"192","author":"Katz","year":"1975","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003279.pub3","article-title":"Treatment for Lambert-Eaton myasthenic syndrome.","volume":"2","author":"Keogh","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ncl.2018.01.008","article-title":"Lambert-eaton myasthenic syndrome.","volume":"36","author":"Kesner","year":"2018","journal-title":"Neurol. Clin."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1042\/BCJ20160084","article-title":"Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment.","volume":"473","author":"Kharlamova","year":"2016","journal-title":"Biochem. J."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a020503","article-title":"Perisynaptic Schwann cells at the neuromuscular synapse: adaptable, multitasking glial cells.","volume":"7","author":"Ko","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.2174\/092986710791111198","article-title":"Structure-activity relationship of quaternary acetylcholinesterase inhibitors - outlook for early myasthenia gravis treatment.","volume":"17","author":"Komloova","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1134\/S0012496615010081","article-title":"Identification of the muscarinic receptor subtypes involved in autoregulation of acetylcholine quantal release from frog motor nerve endings.","volume":"460","author":"Kovyazina","year":"2015","journal-title":"Dokl. Biol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/j.1460-9568.2010.07430.x","article-title":"Kinetics of acetylcholine quanta release at the neuromuscular junction during high-frequency nerve stimulation.","volume":"32","author":"Kovyazina","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/nyas.13555","article-title":"Acetylcholine receptor antibody-mediated animal models of myasthenia gravis and the role of complement.","volume":"1413","author":"Kusner","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/14737175.2017.1241144","article-title":"Myasthenia gravis: recent advances in immunopathology and therapy.","volume":"17","author":"Lee","year":"2017","journal-title":"Expert Rev. Neurother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/nyas.13595","article-title":"Congenital myasthenic syndromes with acetylcholinesterase deficiency, the pathophysiological mechanisms.","volume":"1413","author":"Legay","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/jnc.13373","article-title":"Metabotropic GABAB receptors mediate GABA inhibition of acetylcholine release in the rat neuromuscular junction.","volume":"135","author":"Malomouzh","year":"2015","journal-title":"J. Neurochem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.abb.2009.12.005","article-title":"Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior.","volume":"494","author":"Masson","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"B36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.abb.2016.02.010","article-title":"Slow-binding inhibition of cholinesterases, pharmacological and toxicological relevance.","volume":"593","author":"Masson","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"B37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/sj.bjp.0705010","article-title":"Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions.","volume":"138","author":"Minic","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1046\/j.0953-816x.2001.01875.x","article-title":"Regulation of acetylcholine release by muscarinic receptors at the mouse neuromuscular junction depends on the activity of acetylcholinesterase.","volume":"15","author":"Minic","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11302-015-9465-4","article-title":"Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission.","volume":"11","author":"Nascimento","year":"2017","journal-title":"Purinergic Signal."},{"key":"B40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3233\/JND-170257","article-title":"Congenital myasthenic syndromes or inherited disorders of neuromuscular transmission: recent discoveries and open questions.","volume":"4","author":"Nicole","year":"2017","journal-title":"J. Neuromuscul. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1073\/pnas.98.4.2017","article-title":"Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans.","volume":"98","author":"Ohno","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1046\/j.1460-9568.2002.02020.x","article-title":"Modulation by adenosine of both muscarinic M1-facilitation and M2-inhibition of [3H]-acetylcholine release from the rat motor nerve terminals.","volume":"15","author":"Oliveira","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neulet.2009.05.001","article-title":"Negative crosstalk between M1 and M2 muscarinic autoreceptors involves endogenous adenosine activating A1 receptors at the rat motor endplate.","volume":"459","author":"Oliveira","year":"2009","journal-title":"Neurosci. Lett."},{"key":"B44","doi-asserted-by":"publisher","first-page":"11870","DOI":"10.1523\/JNEUROSCI.0329-14.2014","article-title":"Schwann cells sense and control acetylcholine spillover at the neuromuscular junction by \u03b17 nicotinic receptors and butyrylcholinesterase.","volume":"34","author":"Petrov","year":"2014","journal-title":"J. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18307-9","article-title":"Specific inhibition of acetylcholinesterase as an approach to decrease muscarinic side effects during myasthenia gravis treatment.","volume":"8","author":"Petrov","year":"","journal-title":"Sci. Rep."},{"key":"B46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.33549\/physiolres.930980","article-title":"Different sensitivity of miniature endplate currents of the rat extensor digitorum longus, soleus and diaphragm muscles to a novel acetylcholinesterase inhibitor C-547.","volume":"55","author":"Petrov","year":"2006","journal-title":"Physiol. Res."},{"key":"B47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.33549\/physiolres.931698","article-title":"Different sensitivity of miniature endplate currents in rat external and internal intercostal muscles to the acetylcholinesterase inhibitor C-547 as compared with diaphragm and extensor digitorum longus.","volume":"58","author":"Petrov","year":"2009","journal-title":"Physiol. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/ejn.12029","article-title":"Regulation of acetylcholinesterase activity by nitric oxide in rat neuromuscular junction via N-methyl-D-aspartate receptor activation.","volume":"37","author":"Petrov","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1476-5381.2011.01211.x","article-title":"Different sensitivities of rat skeletal muscles and brain to novel anti-cholinesterase agents, alkylammonium derivatives of 6-methyluracil (ADEMS).","volume":"163","author":"Petrov","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.neuropharm.2017.12.034","article-title":"C-547, a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase: pharmacokinetic and pharmacodynamic studies.","volume":"131","author":"Petrov","year":"","journal-title":"Neuropharmacology"},{"key":"B51","first-page":"1","article-title":"\u201cNeuromuscular junction physiology and pathophysiology,\u201d in","author":"Plomp","year":"2018","journal-title":"Myasthenia Gravis and Related Disorders"},{"key":"B52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bcp.2018.01.044","article-title":"Cholinesterases and the fine line between poison and remedy.","volume":"153","author":"Pope","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.etap.2004.12.048","article-title":"Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action.","volume":"19","author":"Pope","year":"2005","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"B54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-3-319-62067-1_8","article-title":"\u201cClinical pharmacology of drugs acting at the neuromuscular junction,\u201d in","author":"Renew","year":"2018","journal-title":"Basic Sciences in Anesthesia"},{"key":"B55","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.1523\/JNEUROSCI.15-11-07121.1995","article-title":"Purinergic receptors and their activation by endogenous purines at perisynaptic glial cells of the frog neuromuscular junction.","volume":"15","author":"Robitaille","year":"1995","journal-title":"J. Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1469-7793.1997.337be.x","article-title":"Muscarinic Ca2+ responses resistant to muscarinic antagonists at perisynaptic Schwann cells of the frog neuromuscular junction.","volume":"504","author":"Robitaille","year":"1997","journal-title":"J. Physiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1523\/JNEUROSCI.21-11-03819.2001","article-title":"Synapse-glia interactions at the mammalian neuromuscular junction.","volume":"21","author":"Rochon","year":"2001","journal-title":"J. Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/mus.22177","article-title":"Endplate contributions to the safety factor for neuromuscular transmission.","volume":"44","author":"Ruff","year":"2011","journal-title":"Muscle Nerve"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1111\/j.1460-9568.2006.04753.x","article-title":"Muscarinic autoreceptors modulate transmitter release through protein kinase C and protein kinase A in the rat motor nerve terminal.","volume":"23","author":"Santaf\u00e9","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.neuroscience.2007.06.017","article-title":"Coupling of presynaptic muscarinic autoreceptors to serine kinases in low and high release conditions on the rat motor nerve terminal.","volume":"148","author":"Santaf\u00e9","year":"2007","journal-title":"Neuroscience"},{"key":"B61","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1046\/j.1460-9568.2003.02428.x","article-title":"Modulation of ACh release by presynaptic muscarinic autoreceptors in the neuromuscular junction of the newborn and adult rat.","volume":"17","author":"Santaf\u00e9","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuroscience.2003.09.012","article-title":"Muscarinic autoreceptors related with calcium channels in the strong and weak inputs at polyinnervated developing rat neuromuscular junctions.","volume":"123","author":"Santaf\u00e9","year":"2004","journal-title":"Neuroscience"},{"key":"B63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1113\/jphysiol.1994.sp020176","article-title":"ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings.","volume":"477","author":"Silinsky","year":"1994","journal-title":"J. Physiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/neu.10139","article-title":"The nicotinic receptor ligand binding domain.","volume":"53","author":"Sine","year":"2002","journal-title":"J. Neurobiol."},{"key":"B65","first-page":"27","article-title":"\u201cReliability of neuromuscular transmission and how it is maintained,\u201d in","author":"Slater","year":"2009","journal-title":"Neuromuscular Junction Disorders: Handbook of Clinical Neurology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pneurobio.2015.09.004","article-title":"The functional organization of motor nerve terminals.","volume":"134","author":"Slater","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102183","article-title":"The structure of human neuromuscular junctions: some unanswered molecular questions.","volume":"18","author":"Slater","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1469-7793.2001.00717.x","article-title":"Presynaptic M(2) muscarinic receptors are involved in controlling the kinetics of ACh release at the frog neuromuscular junction.","author":"Slutsky","year":"2001","journal-title":"J. Physiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/B978-008045046-9.01132-3","article-title":"\u201cAcetylcholinesterase,\u201d in","author":"Taylor","year":"2009","journal-title":"Encyclopedia of Neuroscience"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/j.1460-9568.2007.05385.x","article-title":"Neurotrophins modulate neuron-glia interactions at a vertebrate synapse.","volume":"25","author":"Todd","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"11870","DOI":"10.1523\/JNEUROSCI.3165-10.2010","article-title":"Perisynaptic glia discriminate patterns of motor nerve activity and influence plasticity at the neuromuscular junction.","volume":"30","author":"Todd","year":"2010","journal-title":"J. Neurosci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1021\/acschemneuro.7b00185","article-title":"Drug-target kinetics in drug discovery.","volume":"9","author":"Tonge","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1517\/17460441.2010.512037","article-title":"Rebinding: or why drugs may act longer in vivo than expected from their in vitro target residence time.","volume":"5","author":"Vauquelin","year":"2010","journal-title":"Expert Opin. Drug Discov."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1517\/17460441.2015.1067196","article-title":"On the \u2018micro\u2019-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action.","volume":"10","author":"Vauquelin","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1111\/bph.13504","article-title":"Effects of target binding kinetics on in vivo drug efficacy: koff, kon and rebinding.","volume":"173","author":"Vauquelin","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1476-5381.2010.00936.x","article-title":"Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action.","volume":"161","author":"Vauquelin","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/B978-0-444-63432-0.00024-4","article-title":"\u201cNeuromuscular junction disorders,\u201d in","author":"Verschuuren","year":"2016","journal-title":"Autoimmune Neurology: Handbook of Clinical Neurology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nchembio.1796","article-title":"Translating slow-binding inhibition kinetics into cellular and in vivo effects.","volume":"11","author":"Walkup","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/nyas.13472","article-title":"Homeostatic synaptic plasticity at the neuromuscular junction in myasthenia gravis.","volume":"1412","author":"Wang","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B80","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/BF00166975","article-title":"Muscarine receptors on the rat phrenic nerve, evidence for positive and negative muscarinic feedback mechanisms.","volume":"1987","author":"Wessler","year":"1987","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0301-0082(00)00055-1","article-title":"Safety factor at the neuromuscular junction.","volume":"64","author":"Wood","year":"2001","journal-title":"Prog. Neurobiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00766\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T18:57:56Z","timestamp":1751741876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00766\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,12]]},"references-count":81,"alternative-id":["10.3389\/fphar.2018.00766"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00766","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,12]]},"article-number":"766"}}